Dr. John S. Berestka, MD

Dr. Berestka practices at Minneapolis Eye Center in Minneapolis, Minnesota.

Dr. Berestka's NPI, 1114905072, was assigned on January 2, 2006. Dr. Berestka graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Berestka's Minnesota license number on file is 38104.

Dr. Berestka's primary practice is Minneapolis Eye Center, at 8401 Golden Valley Rd, Minneapolis, MN 55427 in Hennepin County. The practice phone is (763) 383-4150.

Dr. Berestka's primary practice is Minneapolis Eye Center in Minneapolis, Minnesota. Dmand AI also links Dr. Berestka to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berestka practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Berestka's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Berestka is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Berestka's licenses on file in 2 states: Minnesota and Illinois.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Berestka treats.

CMS data shows 1,271 Medicare services from Dr. Berestka across 17 procedure codes in 2024, for 476 Medicare patients. Medicare paid $137,226 for them.

CMS counts 476 Medicare patients who saw Dr. Berestka in 2024. The largest group is 75 to 84, with 194 patients. 64% of them have high cholesterol, and 55% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berestka's median patient age at 77, with 62% women.

In 2024, Dr. Berestka wrote 1,680 Medicare Part D claims for 405 patients. 72% of them were for generic drugs. CMS names the drug for 1,578 of them, across 19 drugs with 11 or more claims each, at $121,037 in total drug cost. In 2023, CMS named 2,082 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Berestka for performance year 2024, reported as part of a group. Dr. Berestka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of cataract surgery by Dr. Berestka, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Berestka. The most frequent topics are Circadian Rhythm and Rats, Inbred Strains.

CMS Open Payments shows 19 general payments to Dr. Berestka from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Carl Zeiss Meditec, Inc. paid the most, $1,950.

Dmand AI lists 3 awards for Dr. Berestka, most recently Regional Top Doctor in 2014.

Dr. Berestka graduated from The Johns Hopkins University School of Medicine in 1990. Dr. Berestka is a member of AAO and American Society of Cataract and Refractive Surgery.

Dr. Berestka is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Medica. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.